(Q34980036)

5 August 2017

1 reference

title

Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts (English)

1 reference

evasion of host immune response

5 August 2017

1 reference

1 reference

1 reference

Mohty M

1

1 reference

5 August 2017

Olive D

series ordinal

2

1 reference

5 August 2017

Gaugler B

series ordinal

3

1 reference

5 August 2017

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

11

1 reference

5 August 2017

2197-2204

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402710

5 August 2017

0 references

cites work

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and t

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Growth and differentiation of human dendritic cells from CD34+ progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells differentiated from human monocytes through a combination of IL-4, GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Differentiation of human dendritic cells from monocytes in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Monoclonal antibodies against human dendritic cell-like peripheral blood monocytes activated by granulocyte/macrophage-colony-stimulating factor plus interleukin 4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The role of IL-13 in the generation of dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Langerhans cells in human lung tumours: an immunohistological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Human renal-cell carcinoma tissue contains dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

CD4 T cells and their role in antitumor immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The nature of the principal type 1 interferon-producing cells in human blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Signaling and transcription in T helper development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Type I interferon-mediated stimulation of T cells by CpG DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Cytokine research: the interferon paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Interferon affects cell growth progression by modulating DNA polymerases activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Activation and function of natural killer cell responses during viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Clinical and biologic features of CD4+CD56+ malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The hematopoietic development of dendritic cells: a distinct pathway for myeloid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cell development: multiple pathways to nature's adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Nodular lesions of monocytic component in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Plasmacytoid monocytes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Characterization of a common precursor population for dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Post-remission treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Generation of dendritic cells from leukaemia cells of a patient with acute promyelocytic leukaemia by culture with GM-CSF, IL-4 and TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Dendritic cells in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Inhibition of cell-mediated immunity by IL4 and IL10.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Regression of engineered tumor cells secreting cytokines is related to a shift in host cytokine profile from type 2 to type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

The critical role of Th1-dominant immunity in tumor immunology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

CD4+ T helper 1 cells facilitate regression of murine Lyme carditis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402710

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402710

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference